Obesity and Bariatric Surgery
Obesity has become a global health problem that contributes to numerous life-threatening and disabling diseases, such as type 2 diabetes mellitus and coronary artery disease. The long-term results of traditional weight loss therapies, including diet, exercise, and medications, are relatively poor. Bariatric surgery is the most effective treatment of morbidly obese patients to allow substantial, sustained weight loss and to improve or resolve obesity-associated comorbidities, thereby reducing mortality.
Related Conference of Obesity and Bariatric Surgery
Obesity and Bariatric Surgery Conference Speakers
Recommended Sessions
- Analytical Platforms in Metabolomics
- Cancer Therapeutic Approaches
- Clinical Metabolomics & Lipidomics
- Data Analysis & Systems Biology
- Enhancing Analytical Approaches
- Food & Nutritional Metabolomics
- Frontiers of Metabolomics Research
- Metabolic Modelling and Synthetic Biology
- Metabolic Syndrome
- Metabolomic devices
- Metabolomics in Precision Medicine
- Obesity and Bariatric Surgery
- Plant & Environmental Metabolomics
- Proteomics in Medicine
- Therapeutic Metabolomics
- Transcriptomics & Metabolic pathways
Related Journals
Are you interested in
- Advanced Biofuels and Sustainable Fuel Technologies - Biodiesel 2027 (France)
- Algae-Based Biofuels and Marine Bioenergy - Biodiesel 2027 (France)
- Biogas, Biomethane and Anaerobic Digestion - Biodiesel 2027 (France)
- Biohydrogen and Hydrogen Production from Biomass - Biodiesel 2027 (France)
- Biomass Conversion and Bioenergy Technologies - Biodiesel 2027 (France)
- Biorefineries and Integrated Biomass Processing - Biodiesel 2027 (France)
- Lignocellulosic Biomass and Cellulosic Biofuels - Biodiesel 2027 (France)
- Pyrolysis, Gasification and Hydrothermal Conversion - Biodiesel 2027 (France)
- Sustainable Aviation Fuels and Renewable Transportation - Biodiesel 2027 (France)
- Sustainable Biomass Feedstocks and Supply Chains - Biodiesel 2027 (France)
